Y-Intercept (HK)
BIOA icon

Y-Intercept (HK)’s BioAge Labs BIOA Stock Holding History

Y-Intercept (HK)’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.25M Buy
316,767
+301,527
+1,979% +$4.18M 0.05% 573
2026
Q2 		$374K Sell
15,240
-186,097
-92% -$3.36M 0.01% 1401
2026
Q1 		$3.52M Buy
+201,337
New +$3.88M 0.07% 463

Other funds holding BIOA

Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
True Wealth Design
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Y-Intercept (HK)'s BIOA Position: Q3 2026 in Review

Y-Intercept (HK) increased its BioAge Labs (BIOA) stake by 1,979% in Q3 2026, buying an estimated $4.18M and bringing the position to 316,767 shares worth $2.25M. The position accounts for 0.05% of the portfolio, ranked #573.

Y-Intercept (HK) first reported a position in BIOA in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.52M in Q1 2026. 11 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.

  • Y-Intercept (HK) held 316,767 shares of BioAge Labs worth $2.25M as of Q3 2026.
  • Y-Intercept (HK) bought 301,527 BioAge Labs shares in Q3 2026, an estimated $4.18M.
  • BioAge Labs made up 0.05% of Y-Intercept (HK)'s portfolio in Q3 2026, its #573 holding.
  • Y-Intercept (HK) first reported a position in BioAge Labs in Q1 2026 and has held it in 3 quarters since.
  • Y-Intercept (HK)'s BioAge Labs position peaked at $3.52M in Q1 2026.
  • 11 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.